|
MIPOL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62936331093988E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.99760216648792E-15 |
| Normal-vs-Stage2 |
3.34650085420662E-11 |
| Normal-vs-Stage3 |
2.52020626589911E-14 |
| Normal-vs-Stage4 |
4.9960036108132E-15 |
| Stage1-vs-Stage2 |
3.551400E-01 |
| Stage1-vs-Stage3 |
5.792600E-01 |
| Stage1-vs-Stage4 |
3.813400E-01 |
| Stage2-vs-Stage3 |
6.380200E-01 |
| Stage2-vs-Stage4 |
1.685380E-01 |
| Stage3-vs-Stage4 |
2.345200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.44169137633799E-15 |
| Normal-vs-AfricanAmerican |
5.69470000000294E-05 |
| Normal-vs-Asian |
1.64002145197628E-12 |
| Caucasian-vs-AfricanAmerican |
9.702100E-02 |
| Caucasian-vs-Asian |
6.050200E-01 |
| AfricanAmerican-vs-Asian |
7.173500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62525548574877E-12 |
| Normal-vs-Female |
1.63524749297039E-12 |
| Male-vs-Female |
1.959040E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62936331093988E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62891922173003E-12 |
| Normal-vs-Age(81-100Yrs) |
6.09039996213312E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.794000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.022000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.696400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.272000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.925400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.774400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.603600E-02 |
| Classical-VS-Follicular |
7.356000E-02 |
| Classical-VS-Other |
6.928200E-01 |
| Classical-VS-Normal |
1.98074889823374E-12 |
| Tall-VS-Follicular |
6.030800E-01 |
| Tall-VS-Other |
5.704400E-01 |
| Tall-VS-Normal |
1.63336011382853E-12 |
| Follicular-VS-Other |
8.382600E-01 |
| Follicular-VS-Normal |
1.63280500231622E-12 |
| Other-VS-Normal |
3.221700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62525548574877E-12 |
| N0-vs-N1 |
1.898000E-01 |
|
|
